Endometrial Cancer Trial, Recruiting (NCT07209917)

Endometrial Cancer Trial, Recruiting NCT07209917 Sponsor: University of California, Irvine Condition: Endometrial Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07209917 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometrial Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a woman living with HIV, between 25 and 50 years old
You have been taking HIV medication (antiretroviral therapy) for more than 12 months and can show your medication card as proof
You have tested positive for high-risk HPV (a virus linked to cervical cancer) using a specific lab test, but a visual examination of your cervix came back normal (no concerning changes seen)
You have not taken part in the earlier Phase I part of this research study

Who may not be able to join:

You are currently pregnant or breastfeeding
You are older than 50 years of age (if this applies to you, the trial team will refer you directly to a specialist)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Adey Nyamathi, ANP, PhD, FAAN, UCI Sue & Bill Gross School of Nursing

Phone: 91-80-26995180/5877

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07209917

Sponsor: University of California, Irvine

Phase: Not Applicable

Status: Recruiting

Condition: Endometrial Cancer

Trial contact: 91-80-26995180/5877

More information: https://clinicaltrials.gov/study/NCT07209917

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a woman living with HIV, between 25 and 50 years old
You have been taking HIV medication (antiretroviral therapy) for more than 12 months and can show your medication card as proof
You have tested positive for high-risk HPV (a virus linked to cervical cancer) using a specific lab test, but a visual examination of your cervix came back normal (no concerning changes seen)
You have not taken part in the earlier Phase I part of this research study

Who may not be able to join:

You are currently pregnant or breastfeeding
You are older than 50 years of age (if this applies to you, the trial team will refer you directly to a specialist)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of California, Irvine

Registry

ClinicalTrials.gov

Start date

1 February 2026

Est. completion

30 April 2029

Where this trial is recruiting

🇮🇳 India

Primary endpoints

HR-HPV Detection

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov